Clinical TrialID 181
Bioavailability of Xanthones From Mangosteen
NCT01425047
Healthy Volunteers
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 181
- Evidence Id
- 181
- Core Evidence Id
- 181
- Source Clinical Trial Id
- 175
- Herb2 Clinical Trial Id
- HBCT000175
- Nct Id
- NCT01425047
- Title
- Bioavailability of Xanthones From Mangosteen
- Status
- Completed
- Phase
- Study Result
- No
- Study Condition
- Healthy Volunteers
- Study Type
- Observational
- Study Design
- Observational Model: |Time Perspective: p
- Intervention
- Intervention Allocation
- Intervention Model
- Intervention Mask
- Intervention Purpose
- Gender
- All
- Age
- Adult
- Enrollment
- 10
- Outcome Measure
- Xanthones in urine, Urine was collected prior to ingesting mangosteen juice with breakfast and then from consumpotion of juice until 24h., 0-24 hours
- Sponsor Collaborator
- Mark Failla|Ohio State University
- Funded By
- OTHER
- Location
- The Ohio State University, Clinical Research Center, Columbus, Ohio, 43210, United States
- Other Id
- 2010H0219
- Start Date
- 2010-11
- Primary Completion Date
- 2010-11
- Completion Date
- 2011-02
- First Posted
- 2011-08-29
- Results First Posted
- Last Update Posted
- 2011-09-02
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT01425047
- Title Cn
- Title En
- Bioavailability of Xanthones From Mangosteen
- Bilingual Status
- semi_complete